Please login to the form below

Not currently logged in


This page shows the latest immunotherapies news and features for those working in and with pharma, biotech and healthcare.

Immutep spikes on trial of its LAG-3 drug with Keytruda

Immutep spikes on trial of its LAG-3 drug with Keytruda

Impressive mid-stage results in NSCLC and HNSCC. Shares in Australian biotech Immutep rose quickly on data for its cancer immunotherapy drug eftilagimod alpha alongside Merck &Co’s Keytruda in solid ... for the drug as a standalone immunotherapy.

Latest news

More from news
Approximately 94 fully matching, plus 484 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 5 fully matching, plus 53 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 45 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 11 fully matching, plus 15 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...